Dysarthria in children and adults with ataxia telangiectasia.
Journal
Developmental medicine and child neurology
ISSN: 1469-8749
Titre abrégé: Dev Med Child Neurol
Pays: England
ID NLM: 0006761
Informations de publication
Date de publication:
04 2021
04 2021
Historique:
accepted:
08
12
2020
pubmed:
2
2
2021
medline:
20
8
2021
entrez:
1
2
2021
Statut:
ppublish
Résumé
To investigate the characteristics and severity of dysarthria in children and adults with ataxia telangiectasia. All children and adults with ataxia telangiectasia who visited our multidisciplinary outpatient clinic for ataxia telangiectasia were asked to participate in this study, which took place in March 2019. To evaluate dysarthria, we used the Radboud Dysarthria Assessment in adults (older than 18y) and the paediatric Radboud Dysarthria Assessment in children (5-18y), including the observational tasks 'conversation' and 'reading', and the speech-related maximum performance tasks 'repetition rate', 'phonation time', 'fundamental frequency range', and 'phonation volume'. Speech intelligibility was measured using the Intelligibility in Context Scale. Twenty-two individuals (15 children [5-17y], seven adults [19-47y]; 14 males and eight females; mean age 19y, SD 15y 2mo) participated. Dysarthria was present in all participants and characterized by ataxic components in adults and similar uncontrolled movements in children. In most participants, speech was mildly to mildly/severely affected. Almost all participants had an abnormal score for at least one maximum performance task. Dysarthria in ataxia telangiectasia is characterized by uncontrolled, ataxic, and involuntary movements, resulting in monotonous, unstable, slow, hypernasal, and chanted speech. Dysarthria in ataxia telangiectasia is characterized by uncontrolled, ataxic, and involuntary movements. Dysarthria in ataxia telangiectasia results in monotonous, unstable, slow, hypernasal, and chanted speech. Dysarthria in ataxia telangiectasia can be assessed using the Radboud Dysarthria Assessment and the paediatric Radboud Dysarthria Assessment.
Identifiants
pubmed: 33521952
doi: 10.1111/dmcn.14811
pmc: PMC7986845
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
450-456Subventions
Organisme : Twan foundation
Organisme : A-T Children's Project
Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2021 The Authors. Developmental Medicine & Child Neurology published by John Wiley & Sons Ltd on behalf of Mac Keith Press.
Références
J Speech Lang Hear Res. 2012 Apr;55(2):648-56
pubmed: 22215036
Int J Speech Lang Pathol. 2018 Jun;20(3):350-360
pubmed: 29865957
J Speech Hear Disord. 1987 Nov;52(4):367-87
pubmed: 3312817
Nat Rev Mol Cell Biol. 2013 Apr;14(4):197-210
pubmed: 23486281
Clin Genet. 2015 Mar;87(3):199-208
pubmed: 25040471
Brain Lang. 1982 Mar;15(2):259-91
pubmed: 7074345
Folia Phoniatr Logop. 2017;69(4):143-153
pubmed: 29393211
Dev Neurorehabil. 2011;14(5):315-22
pubmed: 21870956
Pediatr Pulmonol. 2008 Jan;43(1):59-66
pubmed: 18041755
J Pediatr. 2011 Sep;159(3):466-471.e1
pubmed: 21429505
Int J Speech Lang Pathol. 2014 Aug;16(4):355-71
pubmed: 24521506
Int J Speech Lang Pathol. 2019 Feb;21(1):56-64
pubmed: 28949263
J Speech Hear Res. 1969 Jun;12(2):246-69
pubmed: 5808852
Science. 1995 Jun 23;268(5218):1749-53
pubmed: 7792600
J Speech Hear Res. 1993 Jun;36(3):452-9
pubmed: 8331902
Ann Neurol. 2019 Feb;85(2):170-180
pubmed: 30549301
Neurosci Biobehav Rev. 2012 Jan;36(1):439-58
pubmed: 21827785
Hum Mutat. 2012 Mar;33(3):561-71
pubmed: 22213089
Pediatrics. 1958 Apr;21(4):526-54
pubmed: 13542097
Clin Immunol. 2017 May;178:45-55
pubmed: 28126470
Int J Speech Lang Pathol. 2014 Aug;16(4):396-407
pubmed: 24476542